window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 19, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

News

NewsDebbie2026-02-23T12:06:10+00:00
  • All
  • Advanced Therapies
  • Biotech & Pharma Business
  • Central Nervous System
  • Clinical & Regulatory
  • Digital & Data
  • Drug Delivery & Formulation
  • Drug Discovery & Development
  • Genomics and sequencing
  • Manufacturing & Supply Chain
  • Medical devices
  • Opinion & Events
  • Pharmaceuticals and therapeutics
  • Research & Development
  • Therapeutic Areas
  • Uncategorised
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Oryzon reports strong early AML response data from iadademstat combinations at EHA 2026

    read more
  • Digital & Data,Drug Discovery & Development

    Sygnature Discovery partners with DaltonTx to expand AI drug discovery capabilities

    read more
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Medicus files IND for genomics-enabled Phase 2 endometriosis trial

    read more
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Vertex reports positive CASGEVY data in children and completes UK submission

    read more
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Poolbeg presents preclinical POLB 001 data at EHA Congress

    read more
  • Pharmaceuticals and therapeutics,Therapeutic Areas

    Scenic Biotech joins Michael J. Fox Foundation Parkinson’s research programme

    read more
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Poolbeg begins patient recruitment for POLB 001 TOPICAL trial

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    China approves Symproic for opioid-induced constipation

    read more
  • Drug Discovery & Development,Pharmaceuticals and therapeutics

    Scripps researchers develop stereoretentive radical chemistry for drug discovery

    read more
  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Therapeutic Areas

    FDA grants orphan drug designation to Tris Pharma’s TRN-257 for idiopathic hypersomnia

    read more
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    PhoreMost advances brain cancer candidate PMC-001 towards Phase 1

    read more
  • Advanced Therapies,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    OrganaBio to manufacture RxMP haemostatic therapy RMP-402

    read more
  • Biotech & Pharma Business,Drug Delivery & Formulation,Drug Discovery & Development

    Symeres expands spray drying capacity at New Jersey site to support poorly soluble small molecules

    read more
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Axplora consolidates UDCA manufacturing at Vizag site to strengthen integrated global supply and support future growth

    read more
  • Biotech & Pharma Business,Drug Delivery & Formulation,Drug Discovery & Development,Genomics and sequencing

    European WiFIX consortium wins €1m Eurostars grant for Nexopore nucleic acid delivery technology

    read more
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics

    Dicot Pharma raises €21M after oversubscribed SEK 231M rights issue to advance LIB-01 into Phase 2b

    read more
Previous91011Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Genespire reports preclinical gene therapy data for methylmalonic acidemia
    Categories: Advanced Therapies, Genomics and sequencing, Research & Development, Therapeutic Areas
  • FORE Biotherapeutics completes enrolment in registrational plixorafenib brain tumour study
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Study quantifies financial benefits of risk-based quality management in oncology trials
    Categories: Clinical & Regulatory, Digital & Data, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top